Abbott Laboratories Operating Margin 2006-2020 | ABT

Current and historical operating margin for Abbott Laboratories (ABT) over the last 10 years. The current operating profit margin for Abbott Laboratories as of June 30, 2020 is 17.17%.
Abbott Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2020-06-30 $31.44B $4.02B 12.78%
2020-03-31 $32.10B $4.55B 14.18%
2019-12-31 $31.90B $4.53B 14.21%
2019-09-30 $31.36B $4.31B 13.74%
2019-06-30 $30.94B $4.11B 13.27%
2019-03-31 $30.72B $3.78B 12.31%
2018-12-31 $30.58B $3.65B 11.94%
2018-09-30 $30.40B $3.14B 10.32%
2018-06-30 $29.58B $2.91B 9.84%
2018-03-31 $28.45B $2.41B 8.49%
2017-12-31 $27.39B $1.56B 5.71%
2017-09-30 $25.13B $1.70B 6.77%
2017-06-30 $23.61B $1.83B 7.75%
2017-03-31 $22.30B $2.26B 10.13%
2016-12-31 $20.85B $3.03B 14.51%
2016-09-30 $20.71B $3.05B 14.74%
2016-06-30 $20.56B $2.87B 13.95%
2016-03-31 $20.39B $2.78B 13.64%
2015-12-31 $20.41B $2.87B 14.05%
2015-09-30 $20.57B $2.88B 14.00%
2015-06-30 $20.50B $2.90B 14.13%
2015-03-31 $20.39B $2.84B 13.95%
2014-12-31 $20.25B $2.60B 12.84%
2014-09-30 $18.90B $2.19B 11.58%
2014-06-30 $18.65B $1.93B 10.37%
2014-03-31 $19.03B $1.88B 9.89%
2013-12-31 $19.66B $2.13B 10.85%
2013-09-30 $18.84B $1.69B 8.98%
2013-06-30 $19.28B $1.53B 7.93%
2013-03-31 $19.14B $1.47B 7.66%
2012-12-31 $19.05B $1.36B 7.14%
2012-09-30 $26.24B $3.47B 13.21%
2012-06-30 $30.79B $3.75B 12.18%
2012-03-31 $35.09B $4.96B 14.13%
2011-12-31 $38.85B $5.75B 14.80%
2011-09-30 $38.44B $5.50B 14.30%
2011-06-30 $37.30B $6.09B 16.31%
2011-03-31 $36.51B $5.92B 16.21%
2010-12-31 $35.17B $6.09B 17.31%
2010-09-30 $33.99B $6.12B 18.01%
2010-06-30 $33.08B $6.58B 19.89%
2010-03-31 $31.74B $6.65B 20.93%
2009-12-31 $30.76B $6.24B 20.27%
2009-09-30 $29.92B $6.12B 20.44%
2009-06-30 $29.66B $5.87B 19.80%
2009-03-31 $29.48B $5.61B 19.02%
2008-12-31 $29.53B $5.70B 19.29%
2008-09-30 $28.80B $5.47B 18.99%
2008-06-30 $27.68B $5.00B 18.06%
2008-03-31 $26.74B $4.78B 17.88%
2007-12-31 $25.92B $4.58B 17.67%
2007-09-30 $25.52B $2.83B 11.09%
2007-06-30 $24.71B $2.59B 10.48%
2007-03-31 $23.84B $1.95B 8.17%
2006-12-31 $22.48B $2.04B 9.09%
2006-09-30 $21.70B $3.58B 16.48%
2006-06-30 $21.51B $3.72B 17.28%
2006-03-31 $21.54B $4.27B 19.83%
2005-12-31 $22.34B $4.36B 19.53%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $179.231B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 24.99
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.39
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.736B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.673B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 179.15
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
OraSure Technologies (OSUR) United States $0.872B 0.00
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.599B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
InfuSystems Holdings (INFU) United States $0.278B 154.11
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00